Expertise in
11
conditions

Dr. Maxwell M. Krem

Oncology
Curators Of The University Of Missouri
1 Hospital Dr, 
Columbia, MO 
Accepting New Patients
Expertise in
11
conditions
Curators Of The University Of Missouri
1 Hospital Dr, 
Columbia, MO 

Overview

Maxwell Krem is an Oncologist practicing medicine in Columbia, Missouri.

Dr. Krem is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Bone Graft, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 5 clinical trials. Dr. Krem is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in KY

Hospital Affiliations

University Of Missouri Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

Curators of the University of Missouri
1 Hospital Dr, Columbia, MO 65212

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Drug, Biological, Procedure, Other, Radiation
Study Drugs: Brentuximab, Dacarbazine, Doxorubicin, Filgrastim, Nivolumab, Pegfilgrastim, Vinblastine
Study Phase: Phase 3
A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission
A Randomized Phase III Trial of Consolidation With Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs Maintenance Rituximab Alone for Patients With Mantle Cell Lymphoma in Minimal Residual Disease-Negative First Complete Remission
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2026
Intervention Type: Biological, Procedure
Study Drug: Rituximab
Study Phase: Phase 3
Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Phase 2 Study of Copanlisib in Combination With Nivolumab in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Biological, Drug
Study Drugs: Copanlisib Hydrochloride, Nivolumab
Study Phase: Phase 2
A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
A Multicenter, Randomized, Open-label Phase 2 Study Evaluating the Safety and Efficacy of Three Different Regimens of Oral Panobinostat in Combination With Subcutaneous Bortezomib and Oral Dexamethasone in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Who Have Been Previously Exposed to Immunomodulatory Agents
Enrollment Status: Completed
Publish Date: July 12, 2024
Intervention Type: Drug
Study Drugs: Panobinostat Capsules, Bortezomib Injection, Dexamethasone Tablets
Study Phase: Phase 2
Phase 2 Trial of the Heat Shock Protein-90 (Hsp90) Inhibitor AT13387 (Onalespib) in Patients With Relapsed/Refractory ALK+ ALCL, Mantle Cell Lymphoma, and BCL6+ DLBCL
Phase 2 Trial of the Heat Shock Protein-90 (Hsp90) Inhibitor AT13387 (Onalespib) in Patients With Relapsed/Refractory ALK+ ALCL, Mantle Cell Lymphoma, and BCL6+ DLBCL
Enrollment Status: Terminated
Publish Date: September 13, 2022
Intervention Type: Drug
Study Drug: Onalespib
Study Phase: Phase 2
View 4 Less Clinical Trials

46 Total Publications

Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.
Journal: Blood neoplasia
Published: March 10, 2025
Similar Doctors
Expertise in
83
conditions
Dr. Umasankar Ramadoss
Hematology | Oncology
Expertise in
83
conditions
Dr. Umasankar Ramadoss
Hematology | Oncology
Referral may be required

Boone Hospital Center

1600 E Broadway, 
Columbia, MO 
 (1.0 miles away)
573-815-8000
Languages Spoken:
English
See accepted insurances

Umasankar Ramadoss is a Hematologist and an Oncologist practicing medicine in Columbia, Missouri. Dr. Ramadoss is highly rated in 83 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, Bone Marrow Aspiration, and Liver Embolization.

Expertise in
64
conditions
Expertise in
64
conditions
Referral may be required

Missouri Cancer Associates Rrl

1705 E Broadway Ste 100, 
Columbia, MO 
 (5.4 miles away)
573-874-7800
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Tungesvik is an Oncologist practicing medicine in Columbia, Missouri. Dr. Tungesvik is highly rated in 64 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Bone Marrow Aspiration, and Endoscopy. Dr. Tungesvik is currently accepting new patients.

Expertise in
9
conditions
Dr. Puja Nistala
Hematology | Oncology
Expertise in
9
conditions
Dr. Puja Nistala
Hematology | Oncology
Referral may be required

The Curators Of The University Of Missouri

1 Hospital Dr, 
Columbia, MO 
 (0.1 miles away)
573-882-4141
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Puja Nistala is a Hematologist and an Oncologist practicing medicine in Columbia, Missouri. Dr. Nistala is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Inflammatory Breast Cancer, and Bone Marrow Aspiration. Dr. Nistala is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine/Hematology. Dr. Nistala is currently accepting new patients.

Frequently Asked Questions about Dr. Maxwell M. Krem

How do I make an appointment with Dr. Maxwell M. Krem?

You can book an appointment with Dr. Maxwell M. Krem by calling their office at 573-882-8445. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Maxwell M. Krem a top-rated expert for Chronic Graft Versus Host Disease (cGvHD)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Maxwell M. Krem is classified as an Advanced expert for Chronic Graft Versus Host Disease (cGvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Maxwell M. Krem specialize in?

While Dr. Maxwell M. Krem is a Oncology, they have specific expertise in Chronic Graft Versus Host Disease (cGvHD), Diffuse Large B-Cell Lymphoma (DLBCL), and Acute Myeloid Leukemia (AML). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Maxwell M. Krem participate in research or clinical trials?

Yes. Dr. Maxwell M. Krem has published 46 articles and abstracts on conditions like Chronic Graft Versus Host Disease (cGvHD). You can view a list of Dr. Maxwell M. Krem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Maxwell M. Krem accept my insurance?

Dr. Maxwell M. Krem accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 573-882-8445 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krem's expertise for a condition
ConditionClose
      View All 11 Advanced Conditions
      View All 32 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile